- Home
- RDGT vs GTBP Comparison
RDGT vs GTBP Comparison
Compare RDGT & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDGT
- GTBP
- Stock Information
- Founded
- RDGT N/A
- GTBP 1965
- Country
- RDGT China
- GTBP United States
- Employees
- RDGT N/A
- GTBP N/A
- Industry
- RDGT
- GTBP Biotechnology: Pharmaceutical Preparations
- Sector
- RDGT
- GTBP Health Care
- Exchange
- RDGT NYSE
- GTBP Nasdaq
- Market Cap
- RDGT 5.7M
- GTBP 5.5M
- IPO Year
- RDGT N/A
- GTBP N/A
- Fundamental
- Price
- RDGT N/A
- GTBP $2.78
- Analyst Decision
- RDGT
- GTBP Strong Buy
- Analyst Count
- RDGT 0
- GTBP 1
- Target Price
- RDGT N/A
- GTBP $11.00
- AVG Volume (30 Days)
- RDGT 7.6K
- GTBP 85.3K
- Earning Date
- RDGT 07-29-2025
- GTBP 08-13-2025
- Dividend Yield
- RDGT N/A
- GTBP N/A
- EPS Growth
- RDGT N/A
- GTBP N/A
- EPS
- RDGT N/A
- GTBP N/A
- Revenue
- RDGT $147,126,392.00
- GTBP N/A
- Revenue This Year
- RDGT N/A
- GTBP N/A
- Revenue Next Year
- RDGT N/A
- GTBP N/A
- P/E Ratio
- RDGT N/A
- GTBP N/A
- Revenue Growth
- RDGT N/A
- GTBP N/A
- 52 Week Low
- RDGT $0.72
- GTBP $1.72
- 52 Week High
- RDGT $4.50
- GTBP $4.10
- Technical
- Relative Strength Index (RSI)
- RDGT N/A
- GTBP 49.54
- Support Level
- RDGT N/A
- GTBP $2.75
- Resistance Level
- RDGT N/A
- GTBP $3.73
- Average True Range (ATR)
- RDGT 0.00
- GTBP 0.25
- MACD
- RDGT 0.00
- GTBP -0.02
- Stochastic Oscillator
- RDGT 0.00
- GTBP 24.55
About RDGT RIDGETECH INC
Ridgetech Inc formerly China Jo-Jo Drugstores Inc is a retailer and distributor of pharmaceutical products. The company's operating segments include Retail drugstores, Online Pharmacy, and Drug wholesale. Retail drugstores segment sells prescription and over-the-counter medicines, TCM, dietary supplements, medical devices, and sundry items to retail customers. The online pharmacy segment sells drugs through third-party platforms such as Alibaba's Tmall, JD.com, and Amazon.com. It generates maximum revenue from the Retail drugstores segment.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.